is remicade fda approved for sarcoidosis?
Infliximab. An infused TNF inhibitor, infliximab (Remicade®) has been approved for several inflammatory diseases including rheumatoid arthritis and Crohn's disease. Small, short-term studies have shown infliximab to be effec- tive in reducing sarcoidosis symptoms in patients who did not respond to other treatments.